Gh. Tan et Rl. Nelson, PHARMACOLOGICAL TREATMENT OPTIONS FOR NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Mayo Clinic proceedings, 71(8), 1996, pp. 763-768
Non-insulin-dependent diabetes mellitus (NIDDM) is a major health conc
ern for clinicians who are responsible for the care of an aging popula
tion, The relationship between hyperglycemia and the chronic complicat
ions of retinopathy, nephropathy, and neuropathy has been established
in patients with insulin-dependent diabetes mellitus, and it is extrem
ely likely that such a relationship exists in patients with NIDDM as w
ell, Diet and exercise are the cornerstone for the management of NIDDM
, The assessment of glycemic control should determine which patients w
ith NIDDM need more aggressive intervention to control hyperglycemia,
Pharmacologic treatment options include oral administration of the sul
fonylureas, a biguanide, and an a-glucosidase inhibitor and subcutaneo
us administration of insulin, Extensive education about diabetes and s
elf-monitoring of blood glucose levels are important components in max
imizing glycemic control, Additional pharmacologic treatment options a
re necessary when adequate individualized treatment goals are not atta
ined, The goal of therapy is to prevent the onset or progression of lo
ng-term microvascular and macrovascular complications, In this review,
we present the therapeutic options and outline our approach to the ph
armacologic treatment of NIDDM, Relevant medical literature on each tr
eatment modality is reviewed, and the cost of therapy with use of each
medication is provided.